Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The receptor for advanced glycation end-products (RAGE) recognizes several ligands involved in inflammatory diseases. Two circulating soluble isoforms exist: esRAGE derived from alternative splicing and cRAGE generated by the membrane-bound RAGE (FL-RAGE) proteolysis. Together, esRAGE and cRAGE constitute sRAGE and function as decoy receptors preventing FL-RAGE/ligands binding. We determined serum concentration of both, esRAGE and cRAGE, and their ligands AGEs, HMGB1 and S100A8/A9 in a healthy population of 169 subjects aged 20-90 years. cRAGE showed a negative (r=-0.375, P < 0.0001) while AGEs (r=0.160, P=0.0384) and S100A8/A9 (r=0.207, P=0.0091) a positive correlation with age. esRAGE did not change during aging and inversely correlated with Hemoglobin, ALT, insulin, HOMA index, Waist-Hip ratio (W/H), Waist Circumference (WC) and positively with AGEs. cRAGE exhibited also an inverse correlation with WC, W/H, PAI-1, HMGB1, AGEs and S100A8/A9. Age, W/H, HMGB1, S100A8/A9 and AGEs are independent predictors of cRAGE, whereas W/H and AGEs associate with esRAGE. Treatment of cells with glycated albumin reduced cRAGE production and upregulated FL-RAGE. These results indicate that in a healthy population cRAGE is a biomarker of aging while esRAGE represents a more reliable marker of obesity and insulin resistance. Hence, sRAGE isoforms levels could be differentially associated with age-related diseases risk factors.

Original languageEnglish
Pages (from-to)1648-1663
Number of pages16
JournalAging
Volume11
Issue number6
DOIs
Publication statusPublished - Mar 31 2019

Fingerprint

Waist-Hip Ratio
HMGB1 Protein
Protein Isoforms
Ligands
Waist Circumference
Plasminogen Activator Inhibitor 1
Alternative Splicing
Population
Proteolysis
Insulin Resistance
Hemoglobins
Obesity
Biomarkers
Advanced Glycosylation End Product-Specific Receptor
Insulin
Membranes
Serum

Keywords

  • Aging
  • Biomarker
  • Cardiovascular risk
  • Inflammaging
  • Obesity
  • RAGE isoforms

ASJC Scopus subject areas

  • Ageing
  • Cell Biology

Cite this

@article{f15a3eb5b845460782f7fc71d0aefe3a,
title = "Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging",
abstract = "The receptor for advanced glycation end-products (RAGE) recognizes several ligands involved in inflammatory diseases. Two circulating soluble isoforms exist: esRAGE derived from alternative splicing and cRAGE generated by the membrane-bound RAGE (FL-RAGE) proteolysis. Together, esRAGE and cRAGE constitute sRAGE and function as decoy receptors preventing FL-RAGE/ligands binding. We determined serum concentration of both, esRAGE and cRAGE, and their ligands AGEs, HMGB1 and S100A8/A9 in a healthy population of 169 subjects aged 20-90 years. cRAGE showed a negative (r=-0.375, P < 0.0001) while AGEs (r=0.160, P=0.0384) and S100A8/A9 (r=0.207, P=0.0091) a positive correlation with age. esRAGE did not change during aging and inversely correlated with Hemoglobin, ALT, insulin, HOMA index, Waist-Hip ratio (W/H), Waist Circumference (WC) and positively with AGEs. cRAGE exhibited also an inverse correlation with WC, W/H, PAI-1, HMGB1, AGEs and S100A8/A9. Age, W/H, HMGB1, S100A8/A9 and AGEs are independent predictors of cRAGE, whereas W/H and AGEs associate with esRAGE. Treatment of cells with glycated albumin reduced cRAGE production and upregulated FL-RAGE. These results indicate that in a healthy population cRAGE is a biomarker of aging while esRAGE represents a more reliable marker of obesity and insulin resistance. Hence, sRAGE isoforms levels could be differentially associated with age-related diseases risk factors.",
keywords = "Aging, Biomarker, Cardiovascular risk, Inflammaging, Obesity, RAGE isoforms",
author = "Francesco Scavello and Filippo Zeni and Tedesco, {Calogero C.} and Emanuela Mens{\`a} and Fabrizio Veglia and Procopio, {Antonio Domenico} and Bonfigli, {Anna Rita} and Fabiola Olivieri and Angela Raucci",
year = "2019",
month = "3",
day = "31",
doi = "10.18632/aging.101860",
language = "English",
volume = "11",
pages = "1648--1663",
journal = "Aging",
issn = "1945-4589",
publisher = "US Administration on Aging",
number = "6",

}

TY - JOUR

T1 - Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging

AU - Scavello, Francesco

AU - Zeni, Filippo

AU - Tedesco, Calogero C.

AU - Mensà, Emanuela

AU - Veglia, Fabrizio

AU - Procopio, Antonio Domenico

AU - Bonfigli, Anna Rita

AU - Olivieri, Fabiola

AU - Raucci, Angela

PY - 2019/3/31

Y1 - 2019/3/31

N2 - The receptor for advanced glycation end-products (RAGE) recognizes several ligands involved in inflammatory diseases. Two circulating soluble isoforms exist: esRAGE derived from alternative splicing and cRAGE generated by the membrane-bound RAGE (FL-RAGE) proteolysis. Together, esRAGE and cRAGE constitute sRAGE and function as decoy receptors preventing FL-RAGE/ligands binding. We determined serum concentration of both, esRAGE and cRAGE, and their ligands AGEs, HMGB1 and S100A8/A9 in a healthy population of 169 subjects aged 20-90 years. cRAGE showed a negative (r=-0.375, P < 0.0001) while AGEs (r=0.160, P=0.0384) and S100A8/A9 (r=0.207, P=0.0091) a positive correlation with age. esRAGE did not change during aging and inversely correlated with Hemoglobin, ALT, insulin, HOMA index, Waist-Hip ratio (W/H), Waist Circumference (WC) and positively with AGEs. cRAGE exhibited also an inverse correlation with WC, W/H, PAI-1, HMGB1, AGEs and S100A8/A9. Age, W/H, HMGB1, S100A8/A9 and AGEs are independent predictors of cRAGE, whereas W/H and AGEs associate with esRAGE. Treatment of cells with glycated albumin reduced cRAGE production and upregulated FL-RAGE. These results indicate that in a healthy population cRAGE is a biomarker of aging while esRAGE represents a more reliable marker of obesity and insulin resistance. Hence, sRAGE isoforms levels could be differentially associated with age-related diseases risk factors.

AB - The receptor for advanced glycation end-products (RAGE) recognizes several ligands involved in inflammatory diseases. Two circulating soluble isoforms exist: esRAGE derived from alternative splicing and cRAGE generated by the membrane-bound RAGE (FL-RAGE) proteolysis. Together, esRAGE and cRAGE constitute sRAGE and function as decoy receptors preventing FL-RAGE/ligands binding. We determined serum concentration of both, esRAGE and cRAGE, and their ligands AGEs, HMGB1 and S100A8/A9 in a healthy population of 169 subjects aged 20-90 years. cRAGE showed a negative (r=-0.375, P < 0.0001) while AGEs (r=0.160, P=0.0384) and S100A8/A9 (r=0.207, P=0.0091) a positive correlation with age. esRAGE did not change during aging and inversely correlated with Hemoglobin, ALT, insulin, HOMA index, Waist-Hip ratio (W/H), Waist Circumference (WC) and positively with AGEs. cRAGE exhibited also an inverse correlation with WC, W/H, PAI-1, HMGB1, AGEs and S100A8/A9. Age, W/H, HMGB1, S100A8/A9 and AGEs are independent predictors of cRAGE, whereas W/H and AGEs associate with esRAGE. Treatment of cells with glycated albumin reduced cRAGE production and upregulated FL-RAGE. These results indicate that in a healthy population cRAGE is a biomarker of aging while esRAGE represents a more reliable marker of obesity and insulin resistance. Hence, sRAGE isoforms levels could be differentially associated with age-related diseases risk factors.

KW - Aging

KW - Biomarker

KW - Cardiovascular risk

KW - Inflammaging

KW - Obesity

KW - RAGE isoforms

UR - http://www.scopus.com/inward/record.url?scp=85063674422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063674422&partnerID=8YFLogxK

U2 - 10.18632/aging.101860

DO - 10.18632/aging.101860

M3 - Article

C2 - 30903794

AN - SCOPUS:85063674422

VL - 11

SP - 1648

EP - 1663

JO - Aging

JF - Aging

SN - 1945-4589

IS - 6

ER -